pembrolizumab,
Showing 1 - 1 of 1
Acute Myeloid Leukemia, in Relapse Trial in Baltimore, Chapel Hill (pembrolizumab,)
Active, not recruiting
- Acute Myeloid Leukemia, in Relapse
- pembrolizumab,
-
Baltimore, Maryland
- +1 more
Aug 10, 2022